{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:31:23Z","timestamp":1792027883743,"version":"4.4.0"},"reference-count":58,"publisher":"Japan Atherosclerosis Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5551\/jat.37663","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T22:15:33Z","timestamp":1489702533000},"page":"954-969","source":"Crossref","is-referenced-by-count":20,"title":["Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression"],"prefix":"10.5551","volume":"24","author":[{"given":"Chiharu","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo"},{"name":"CREST, Japan Science and Technology Corporation (JST)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kurano","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo"},{"name":"CREST, Japan Science and Technology Corporation (JST)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Nishikawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo"},{"name":"CREST, Japan Science and Technology Corporation (JST)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyuki","family":"Kano","sequence":"additional","affiliation":[{"name":"CREST, Japan Science and Technology Corporation (JST)"},{"name":"Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Juntendo University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomo","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Tsukuba Research Institute, Research & Development Division, Sekisui Medical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junken","family":"Aoki","sequence":"additional","affiliation":[{"name":"CREST, Japan Science and Technology Corporation (JST)"},{"name":"Laboratory of Molecular and Cellular Biochemistry, Graduate School of Pharmaceutical Sciences, Tohoku University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yatomi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Medicine, Graduate School of Medicine, The University of Tokyo"},{"name":"CREST, Japan Science and Technology Corporation (JST)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Day ISCFWT: Thrombosis: a major contributor to the global disease burden. Journal of Thrombosis and Haemostasis, 2014; 12: 1580-1590","DOI":"10.1111\/jth.12698"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Mackman N: Triggers, targets and treatments for thrombosis. Nature, 2008; 451: 914-918","DOI":"10.1038\/nature06797"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC: Plasminogen activator inhibitor-1 genedeficient mice. I. Generation by homologous recombination and characterization. J Clin Invest, 1993; 92: 2746-2755","DOI":"10.1172\/JCI116892"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Tjarnlund-Wolf A, Brogren H, Lo EH, Wang X: Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases. Stroke, 2012; 43: 2833-2839","DOI":"10.1161\/STROKEAHA.111.622217"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Ploplis VA: Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease. Curr Drug Targets, 2011; 12: 1782-1789","DOI":"10.2174\/138945011797635803"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Shimizu T, Uematsu M, Yoshizaki T, Obata JE, Nakamura T, Fujioka D, Watanabe K, Watanabe Y, Kugiyama K: Myocardial Production of Plasminogen Activator Inhibitor-1 is Associated with Coronary Endothelial and Ventricular Dysfunction after Acute Myocardial Infarction. J Atheroscler Thromb, 2016; 23: 557-566","DOI":"10.5551\/jat.32300"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tatsumi K, Mackman N: Tissue Factor and Atherothrombosis. J Atheroscler Thromb, 2015; 22: 543-549","DOI":"10.5551\/jat.30940"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Yamamoto K, Takeshita K, Kojima T, Takamatsu J, Saito H: Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc Res, 2005; 66: 276-285","DOI":"10.1016\/j.cardiores.2004.11.013"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kohler HP, Grant PJ: Plasminogen-activator inhibitor type 1 and coronary artery disease. N Engl J Med, 2000; 342: 1792-1801","DOI":"10.1056\/NEJM200006153422406"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Samad F, Uysal KT, Wiesbrock SM, Pandey M, Hotamisligil GS, Loskutoff DJ: Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc Natl Acad Sci U S A, 1999; 96: 6902-6907","DOI":"10.1073\/pnas.96.12.6902"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Samarakoon R, Higgins SP, Higgins CE, Higgins PJ: TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)\/EGFR(Y845) and Rho\/ROCK signaling. J Mol Cell Cardiol, 2008; 44: 527-538","DOI":"10.1016\/j.yjmcc.2007.12.006"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D: Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb Haemost, 1988; 60: 491-494","DOI":"10.1055\/s-0038-1646997"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Perkins JM, Joy NG, Tate DB, Davis SN: Acute effects of hyperinsulinemia and hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight and obese humans. Am J Physiol Endocrinol Metab, 2015; 309: E168-176","DOI":"10.1152\/ajpendo.00064.2015"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Bryan L, Paugh BS, Kapitonov D, Wilczynska KM, Alvarez SM, Singh SK, Milstien S, Spiegel S, Kordula T: Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness. Mol Cancer Res, 2008; 6: 1469-1477","DOI":"10.1158\/1541-7786.MCR-08-0082"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Thuy AV, Reimann CM, Hemdan NY, Graler MH: Sphingosine 1-phosphate in blood: function, metabolism, and fate. Cell Physiol Biochem, 2014; 34: 158-171","DOI":"10.1159\/000362992"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ito S, Iwaki S, Koike K, Yuda Y, Nagasaki A, Ohkawa R, Yatomi Y, Furumoto T, Tsutsui H, Sobel BE, Fujii S: Increased plasma sphingosine-1-phosphate in obese individuals and its capacity to increase the expression of plasminogen activator inhibitor-1 in adipocytes. Coron Artery Dis, 2013; 24: 642-650","DOI":"10.1097\/MCA.0000000000000033"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Goetzl EJ: Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids. Prostaglandins, 2001; 64: 11-20","DOI":"10.1016\/S0090-6980(01)00104-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kimura T, Tomura H, Mogi C, Kuwabara A, Damirin A, Ishizuka T, Sekiguchi A, Ishiwara M, Im DS, Sato K, Murakami M, Okajima F: Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells. J Biol Chem, 2006; 281: 37457-37467","DOI":"10.1074\/jbc.M605823200"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Igarashi J, Bernier SG, Michel T: Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem, 2001; 276: 12420-12426","DOI":"10.1074\/jbc.M008375200"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, English D: Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest, 2001; 108: 689-701","DOI":"10.1172\/JCI12450"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T: Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. J Biol Chem, 2003; 278: 47281-47290","DOI":"10.1074\/jbc.M306896200"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Sanchez T, Hla T: Structural and functional characteristics of S1P receptors. J Cell Biochem, 2004; 92: 913-922","DOI":"10.1002\/jcb.20127"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Okajima F: Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta, 2002; 1582: 132-137","DOI":"10.1016\/S1388-1981(02)00147-6"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Murata N, Sato K, Kon J, Tomura H, Yanagita M, Kuwabara A, Ui M, Okajima F: Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J, 2000; 352 Pt 3: 809-815","DOI":"10.1042\/bj3520809"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnstrom J, Sevvana M, Egerer-Sieber C, Muller YA, Hla T, Nielsen LB, Dahlback B: Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci U S A, 2011; 108: 9613-9618","DOI":"10.1073\/pnas.1103187108"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Xu N, Dahlback B: A novel human apolipoprotein (apoM). J Biol Chem, 1999; 274: 31286-31290","DOI":"10.1074\/jbc.274.44.31286"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Argraves KM, Sethi AA, Gazzolo PJ, Wilkerson BA, Remaley AT, Tybjaerg-Hansen A, Nordestgaard BG, Yeatts SD, Nicholas KS, Barth JL, Argraves WS: S1P, dihydro-S1P and C24: 1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. Lipids Health Dis, 2011; 10: 70","DOI":"10.1186\/1476-511X-10-70"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Sattler KJ, Elbasan S, Keul P, Elter-Schulz M, Bode C, Graler MH, Brocker-Preuss M, Budde T, Erbel R, Heusch G, Levkau B: Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol, 2010; 105: 821-832","DOI":"10.1007\/s00395-010-0112-5"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Wei Y, Liu G, Yang J, Zheng R, Jiang L, Bao P: The association between metabolic syndrome and vascular endothelial dysfunction in adolescents. Exp Ther Med, 2013; 5: 1663-1666","DOI":"10.3892\/etm.2013.1055"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Wilkerson BA, Grass GD, Wing SB, Argraves WS, Argraves KM: Sphingosine 1-phosphate (S1P) carrierdependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. J Biol Chem, 2012; 287: 44645-44653","DOI":"10.1074\/jbc.M112.423426"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Kurano M, Hara M, Tsuneyama K, Sakoda H, Shimizu T, Tsukamoto K, Ikeda H, Yatomi Y: Induction of insulin secretion by apolipoprotein M, a carrier for sphingosine 1-phosphate. Biochim Biophys Acta, 2014; 1841: 1217-1226","DOI":"10.1016\/j.bbalip.2014.05.002"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Blaho VA, Galvani S, Engelbrecht E, Liu C, Swendeman SL, Kono M, Proia RL, Steinman L, Han MH, Hla T: HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Nature, 2015; 523: 342- 346","DOI":"10.1038\/nature14462"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Galvani S, Sanson M, Blaho VA, Swendeman SL, Conger H, Dahlback B, Kono M, Proia RL, Smith JD, Hla T: HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal, 2015; 8: ra79","DOI":"10.1126\/scisignal.aaa2581"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Lee MH, Hammad SM, Semler AJ, Luttrell LM, Lopes-Virella MF, Klein RL: HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate. J Lipid Res, 2010; 51: 2619-2628","DOI":"10.1194\/jlr.M003988"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Dohi T, Miyauchi K, Ohkawa R, Nakamura K, Kishimoto T, Miyazaki T, Nishino A, Nakajima N, Yaginuma K, Tamura H, Kojima T, Yokoyama K, Kurata T, Shimada K, Yatomi Y, Daida H: Increased circulating plasma lysophosphatidic acid in patients with acute coronary syndrome. Clin Chim Acta, 2012; 413: 207-212","DOI":"10.1016\/j.cca.2011.09.027"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Kurano M, Suzuki A, Inoue A, Tokuhara Y, Kano K, Matsumoto H, Igarashi K, Ohkawa R, Nakamura K, Dohi T, Miyauchi K, Daida H, Tsukamoto K, Ikeda H, Aoki J, Yatomi Y: Possible involvement of minor lysophospholipids in the increase in plasma lysophosphatidic acid in acute coronary syndrome. Arterioscler Thromb Vasc Biol, 2015; 35: 463-470","DOI":"10.1161\/ATVBAHA.114.304748"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Okudaira M, Inoue A, Shuto A, Nakanaga K, Kano K, Makide K, Saigusa D, Tomioka Y, Aoki J: Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl2lysophospholipids in biological samples by LC-MS\/MS. J Lipid Res, 2014; 55: 2178-2192","DOI":"10.1194\/jlr.D048439"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Yatomi Y: Plasma sphingosine 1-phosphate metabolism and analysis. Biochim Biophys Acta, 2008; 1780: 606-611","DOI":"10.1016\/j.bbagen.2007.10.006"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Choi OM, Cho YH, Choi S, Lee SH, Seo SH, Kim HY, Han G, Min DS, Park T, Choi KY: The small molecule indirubin-3'-oxime activates Wnt\/beta-catenin signaling and inhibits adipocyte differentiation and obesity. Int J Obes (Lond), 2014; 38: 1044-1052","DOI":"10.1038\/ijo.2013.209"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Kurano M, Tsukamoto K, Hara M, Ohkawa R, Ikeda H, Yatomi Y: LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate. J Biol Chem, 2015; 290: 2477-2488","DOI":"10.1074\/jbc.M114.596445"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Kurano M, Tsukamoto K, Ohkawa R, Hara M, Iino J, Kageyama Y, Ikeda H, Yatomi Y: Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M. Atherosclerosis, 2013; 229: 102-109","DOI":"10.1016\/j.atherosclerosis.2013.04.024"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Kurano M, Iso ON, Hara M, Ishizaka N, Moriya K, Koike K, Tsukamoto K: LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL. Lipids Health Dis, 2011; 10: 134","DOI":"10.1186\/1476-511X-10-134"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T: Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol, 2007; 27: 1312-1318","DOI":"10.1161\/ATVBAHA.107.143735"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Yasar Yildiz S, Kuru P, Toksoy Oner E, Agirbasli M: Functional stability of plasminogen activator inhibitor-1. ScientificWorldJournal, 2014; 2014: 858293","DOI":"10.1155\/2014\/858293"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Frej C, Andersson A, Larsson B, Guo LJ, Norstrom E, Happonen KE, Dahlback B: Quantification of sphingosine 1-phosphate by validated LC-MS\/MS method revealing strong correlation with apolipoprotein M in plasma but not in serum due to platelet activation during blood coagulation. Anal Bioanal Chem, 2015; 407: 8533-8542","DOI":"10.1007\/s00216-015-9008-4"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Yatomi Y, Ohmori T, Rile G, Kazama F, Okamoto H, Sano T, Satoh K, Kume S, Tigyi G, Igarashi Y, Ozaki Y: Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood, 2000; 96: 3431-3438","DOI":"10.1182\/blood.V96.10.3431.h8003431_3431_3438"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Aoki S, Yatomi Y, Ohta M, Osada M, Kazama F, Satoh K, Nakahara K, Ozaki Y: Sphingosine 1-phosphate-related metabolism in the blood vessel. J Biochem, 2005; 138: 47-55","DOI":"10.1093\/jb\/mvi100"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Okazaki H, Ishizaka N, Sakurai T, Kurokawa K, Goto K, Kumada M, Takuwa Y: Molecular cloning of a novel putative G protein-coupled receptor expressed in the cardiovascular system. Biochem Biophys Res Commun, 1993; 190: 1104-1109","DOI":"10.1006\/bbrc.1993.1163"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T: Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest, 2007; 117: 2506-2516","DOI":"10.1172\/JCI31123"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Park SW, Kim M, Brown KM, D'agati VD, Lee HT: Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol, 2012; 23: 266-280","DOI":"10.1681\/ASN.2011050503"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Skoura A, Michaud J, Im DS, Thangada S, Xiong Y, Smith JD, Hla T: Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol, 2011; 31: 81-85","DOI":"10.1161\/ATVBAHA.110.213496"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Hanson MA, Roth CB, Jo E, Griffith MT, Scott FL, Reinhart G, Desale H, Clemons B, Cahalan SM, Schuerer SC, Sanna MG, Han GW, Kuhn P, Rosen H, Stevens RC: Crystal structure of a lipid G protein-coupled receptor. Science, 2012; 335: 851-855","DOI":"10.1126\/science.1215904"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Tsantes AE, Nikolopoulos GK, Bagos PG, Bonovas S, Kopterides P, Vaiopoulos G: The effect of the plasminogen activator inhibitor-1 4G\/5G polymorphism on the thrombotic risk. Thromb Res, 2008; 122: 736-742","DOI":"10.1016\/j.thromres.2007.09.005"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Loskutoff DJ, Ny T, Sawdey M, Lawrence D: Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor. J Cell Biochem, 1986; 32: 273-280","DOI":"10.1002\/jcb.240320404"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Christoffersen C, Nielsen LB, Axler O, Andersson A, Johnsen AH, Dahlback B: Isolation and characterization of human apolipoprotein M-containing lipoproteins. J Lipid Res, 2006; 47: 1833-1843","DOI":"10.1194\/jlr.M600055-JLR200"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Hou B, Eren M, Painter CA, Covington JW, Dixon JD, Schoenhard JA, Vaughan DE: Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. J Biol Chem, 2004; 279: 18127-18136","DOI":"10.1074\/jbc.M310438200"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Laumen H, Skurk T, Hauner H: The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes. Atherosclerosis, 2008; 196: 565-573","DOI":"10.1016\/j.atherosclerosis.2007.06.005"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Iwasaki H, Okamoto R, Kato S, Konishi K, Mizutani H, Yamada N, Isaka N, Nakano T, Ito M: High glucose induces plasminogen activator inhibitor-1 expression through Rho\/Rho-kinase-mediated NF-kappaB activation in bovine aortic endothelial cells. Atherosclerosis, 2008; 196: 22-28","DOI":"10.1016\/j.atherosclerosis.2006.12.025"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/9\/24_37663\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:55:03Z","timestamp":1601772903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/9\/24_37663\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.37663","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}